Ablation of the Thyroid Remnant and I-131 Dose in Differentiated Thyroid Cancer: A Meta-Analysis Revisited
Open Access
- 1 June 2007
- journal article
- review article
- Published by Marshfield Clinic Research Institute in Clinical Medicine & Research
- Vol. 5 (2) , 87-90
- https://doi.org/10.3121/cmr.2007.763
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- 131I Activity for Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Systematic ReviewJournal of Clinical Endocrinology & Metabolism, 2007
- Radioiodine Dose for Remnant Ablation in Differentiated Thyroid Carcinoma: A Randomized Clinical Trial in 509 PatientsJournal of Clinical Endocrinology & Metabolism, 2004
- Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.The British Journal of Radiology, 1998
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994
- Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcomeThe British Journal of Radiology, 1994
- Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*Journal of Clinical Endocrinology & Metabolism, 1990
- Papillary and follicular thyroid cancer: Impact of treatment in 1578 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Evaluation of Low-Dose Radioiodine Ablation Therapy in Postsurgical Thyroid Cancer PatientsClinical Nuclear Medicine, 1985
- Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancerThe American Journal of Medicine, 1976